Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Reception and Implementation of the Japanese Grant of over USD 4 million to 14 Governmental Hospitals

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani met this morning at his office in Bir Hassan with the Japanese Ambassador H.E. Matahiro Yamaguchi to celebrate the completion of the project of USD 4.289.000 Japanese grant aimed at improving 14 government hospitals in Lebanon; in Beirut: Rafic Hariri University Hospital, In Mount-Lebanon: Siblin, Shahar Gharbi, Daher El Bachek and Bouwar, North Lebanon: El Qoubbeh, Halba, and Sir Danniyeh, Beqaa: Zahleh, Baalbeck, Hermel and Rachaya and in South Lebanon: Marjaoun and Hasbaya.

The meeting was followed by a press conference held by Hasbani and the Japanese Ambassador in the presence of directors of the government hospitals that received the Japanese grant.

Arbid

The advisor to the Minister of Public Health Dr. Bahij Arbid noted that the grant aims at “enhancing the quality of services provided in the government hospitals” as he thanked Minister Hasbani who formed a committee for soft loans and grants, the Japanese Embassy and the action team at the Ministry.

Yamaguchi

The Japanese ambassador stated that Lebanon is one of the best countries in the region as to health care services. However, the Lebanese health care sector is trying to cope with the increasing medical needs of the Lebanese citizens and refugees. For this reason, Japan decided to support the Lebanese Ministry of Public Health with an emergency grant amounting to USD 5 million in order to provide 14 government hospitals with Japanese advanced equipment.

Hasbani

Hasbani thanked Japan for “its interest in the Lebanese hospitalization sector”.

"Many more hospitals benefit and will benefit from other grants provided by the Kuwaiti fund for example, which will focus on improving and equipping the emergency departments, in addition to a part of the world bank grant that will be allocated to the government hospitals as part of the financial project we secured this year,” Hasbani noted.
    1
ATC Name B/G Ingredients Dosage Form Price
D06AX01 FUCIDIN CREAM B Fusidic acid - 2% 2% Cream 491,846 L.L
D06AX01 FUCIDIN CREAM B Fusidic acid - 2% 2% Cream 345,368 L.L
M02AA10 FASTUM B Ketoprofen - 2.5g/100g 2.5% Gel 177,387 L.L
M02AA10 FASTUM B Ketoprofen - 2.5g/100g 2.5% Gel 337,304 L.L
L02BA03 FASLODEX B Fulvestrant - 250mg/5ml 250mg/5ml Injectable solution L.L
D06AX01 FUCIDIN B Fusidic acid (sodium salt) - 20mg/g 2% Ointment 259,362 L.L
D06AX01 FUCIDIN OINTMENT B Fusidic acid (sodium salt) - 2% 2% Ointment 491,846 L.L
D06AX01 FUCIDIN OINTMENT B Fusidic acid (sodium salt) - 2% 2% Ointment 345,368 L.L
S01AA13 FUCITHALMIC VISCOUS B Fusidic acid - 10mg/g 1% Drops 443,468 L.L
M02AA15 FLECTOR E.P TISSUGEL B Diclofenac (epolamine) - 1% 1% Patch 1,204,083 L.L
A06AD15 FORLAX POUDRE POUR SOLUTION BUVABLE B Macrogol 4000 - 10g 10g Powder for solution 450,187 L.L
A06AD65 FORTRANS POUDRE POUR SOLUTION BUVABLE B Potassium chloride - 0.750g, Sodium chloride - 1460g, Sodium bicarbonate - 1680g, Sodium sulfate anhydrous - 5700g, Macrogol 4000 - 64.000g Powder for solution 1,136,891 L.L
R03BA05 FLIXOTIDE EVOHALER B Fluticasone propionate - 250mcg/actutaion 250mcg/actutaion Inhalation suspension 1,484,946 L.L
R03BA05 FLIXOTIDE EVOHALER B Fluticasone propionate - 125mcg/actuation 125mcg/actuation Inhalation suspension 802,274 L.L
R03BA05 FLIXOTIDE EVOHALER B Fluticasone propionate - 50mcg/actuation 50mcg/actuation Inhalation suspension 671,921 L.L
S01CA01 FRAKIDEX B Dexamethasone disodium phosphate - 0.1g/100g, Framycetin sulfate - 0.5g/100g Ointment 141,103 L.L
G04B FONCITRIL 4000 B Citric acid - 1.189g, Potassium Citrate - 1.73g, Sodium citrate - 1.845g Granules 1,613,955 L.L
A10BK01 FORXIGA B Dapagliflozin - 10mg 10mg Tablet, film coated 2,927,964 L.L
R03DX10 FASENRA B Benralizumab - 30mg 30mg Injectable solution L.L
C03BA11 FLUDEX B Indapamide - 1.5mg 1.5mg Tablet, sustained release 517,379 L.L
D07CC01 FUCICORT B Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g Cream 376,276 L.L
D07CC01 FUCICORT B Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g Cream 501,253 L.L
R03DX10 FASENRA B Benralizumab - 30mg 30mg Injectable solution 214,213,273 L.L
L02BA03 FASLODEX B Fulvestrant - 250mg/5ml 250mg/5ml Injectable solution 46,628,557 L.L
M05BB03 FOSAVANCE B Alendronic acid (sodium alendronate) - 70mg, Colecalciferol - 5600IU Tablet 1,988,887 L.L
B03AB02 FERRICURE B Iron (polysaccharide complex) - 150mg 150mg Capsule 1,001,163 L.L
B03AB09 FERPLEX B Iron trivalent (ferric proteinsuccinylate) - 800mg 800mg Solution 1,202,739 L.L
R05CB01 FLUIMUCIL B N-acetylcysteine - 600mg 600mg Tablet, effervescent 567,102 L.L
R05CB01 FLUIMUCIL MUCOLYTIC B N-acetylcysteine - 2% 2% Syrup 595,322 L.L
B03AC FERINJECT B Iron trivalent (ferric carboxymaltose) - 500mg/10ml 500mg/10ml Injectable solution 10,212,033 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026